{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:11:44Z","timestamp":1791447104206,"version":"4.3.3"},"reference-count":39,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009933","name":"Johnson & Johnson MedTech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009933","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.hrthm.2026.02.045","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:17:44Z","timestamp":1772853464000},"page":"e980-e989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antiarrhythmic drugs vs catheter ablation for treatment of atrial fibrillation in an elderly population: A retrospective analysis of Medicare Advantage enrollees in the United States"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5240-067X","authenticated-orcid":false,"given":"Robert N.","family":"D\u2019Angelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Locke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximiliano","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"d'Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Zimetbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2026.02.045_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights","volume":"127","author":"Kornej","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2026.02.045_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001624","article-title":"Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM Consortium","volume":"8","author":"Morseth","year":"2021","journal-title":"Open Heart"},{"key":"10.1016\/j.hrthm.2026.02.045_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.55838","article-title":"Prevalence and incidence of atrial fibrillation among older primary care patients","volume":"6","author":"Khurshid","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hrthm.2026.02.045_bib5","first-page":"467","article-title":"Atrial fibrillation associated with heart failure, stroke and mortality","volume":"5","author":"Bordignon","year":"2012","journal-title":"J Atr Fibrillation"},{"key":"10.1016\/j.hrthm.2026.02.045_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007301","article-title":"Association of atrial fibrillation with cognitive decline and dementia over 20 years: the ARIC-NCS (atherosclerosis risk in communities neurocognitive study)","volume":"7","author":"Chen","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2026.02.045_bib7","article-title":"Temporal trends and patterns in atrial fibrillation incidence: a population-based study of 3.4 million individuals","volume":"17","author":"Wu","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.hrthm.2026.02.045_bib8","doi-asserted-by":"crossref","first-page":"448.e1","DOI":"10.1016\/j.amjmed.2005.10.057","article-title":"Quality of life in patients with atrial fibrillation: a systematic review","volume":"119","author":"Thrall","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.hrthm.2026.02.045_bib9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/eurheartj\/eht483","article-title":"Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke","volume":"35","author":"Piccini","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2026.02.045_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2004.03.044","article-title":"Electrophysiologic and electroanatomic changes in the human atrium associated with age","volume":"44","author":"Kistler","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.02.045_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3724\/SP.J.1263.2011.00184","article-title":"Use of antiarrhythmic drugs in elderly patients","volume":"8","author":"Lee","year":"2011","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.hrthm.2026.02.045_bib12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4140\/TCP.n.2015.82","article-title":"Updates in antiarrhythmic therapy for atrial fibrillation in geriatric patients","volume":"30","author":"Ehrlich","year":"2015","journal-title":"Consult Pharm"},{"key":"10.1016\/j.hrthm.2026.02.045_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00002512-200825040-00007","article-title":"Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance","volume":"25","author":"Tulner","year":"2008","journal-title":"Drugs Aging"},{"key":"10.1016\/j.hrthm.2026.02.045_bib14","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.jacc.2006.08.037","article-title":"A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF study","volume":"48","author":"Pappone","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.02.045_bib15","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1161\/CIRCULATIONAHA.108.772582","article-title":"Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study","volume":"118","author":"Ja\u00efs","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.02.045_bib16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jama.2009.2029","article-title":"Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial","volume":"303","author":"Wilber","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2026.02.045_bib17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/eurheartj\/ehi583","article-title":"Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (catheter ablation for the cure of atrial fibrillation study)","volume":"27","author":"Stabile","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2026.02.045_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/eurheartj\/eht457","article-title":"Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)","volume":"35","author":"Mont","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2026.02.045_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.664647","article-title":"Catheter ablation vs. anti-arrhythmic drugs as first-line treatment in symptomatic paroxysmal atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials","volume":"8","author":"Saglietto","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2026.02.045_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/pace.14413","article-title":"Catheter ablation for atrial fibrillation in elderly patients: systematic review and a meta-analysis","volume":"45","author":"Kawamura","year":"2022","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.02.045_bib21","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/jce.15549","article-title":"Catheter ablation for atrial fibrillation in the elderly >75 years old: systematic review and meta-analysis","volume":"33","author":"Prasitlumkum","year":"2022","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.02.045_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.734204","article-title":"Efficacy and safety of ablation for symptomatic atrial fibrillation in elderly patients: a meta-analysis","volume":"8","author":"Lee","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2026.02.045_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae043","article-title":"2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"26","author":"Tzeis","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2026.02.045_bib24","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/CIRCULATIONAHA.121.055297","article-title":"Association between age and outcomes of catheter ablation versus medical therapy for atrial fibrillation: results from the CABANA trial","volume":"145","author":"Bahnson","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.02.045_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007414","article-title":"Catheter ablation versus medical therapy for atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Asad","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.02.045_bib26","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/eurheartj\/ehz085","article-title":"Atrial fibrillation ablation in practice: assessing CABANA generalizability","volume":"40","author":"Noseworthy","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2026.02.045_bib27","doi-asserted-by":"crossref","first-page":"9875","DOI":"10.12659\/MSM.917755","article-title":"Ablation versus medical therapy for atrial fibrillation in the elderly: a propensity score-matched comparison","volume":"25","author":"Wang","year":"2019","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.hrthm.2026.02.045_bib28","first-page":"7343","article-title":"Cardiovascular events and death after catheter ablation in very old patients with nonvalvular atrial fibrillation","volume":"15","author":"Okawa","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.hrthm.2026.02.045_bib29","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.02.045_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.hrthm.2026.02.045_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.hrthm.2026.02.045_bib32","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.hrthm.2026.02.045_bib33","article-title":"Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners","volume":"367","author":"Desai","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2026.02.045_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4097\/kja.d.18.00242","article-title":"What is the proper way to apply the multiple comparison test?","volume":"71","author":"Lee","year":"2018","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.hrthm.2026.02.045_bib35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/europace\/euv010","article-title":"Clinical management of arrhythmias in elderly patients: results of the European Heart Rhythm Association survey","volume":"17","author":"Chen","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2026.02.045_bib36","first-page":"897","article-title":"Periprocedural complications and one-year outcomes after catheter ablation for treatment of atrial fibrillation in elderly patients: a nationwide Danish cohort study","volume":"18","author":"Nielsen","year":"2021","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.hrthm.2026.02.045_bib37","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/clc.24137","article-title":"Safety and efficacy of catheter ablation of atrial fibrillation in the very elderly (\u226580 years old): insights from the UC San Diego AF Ablation Registry","volume":"46","author":"Aldaas","year":"2023","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hrthm.2026.02.045_bib38","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/pace.13932","article-title":"Clinical efficacy and safety of radiofrequency catheter ablation for atrial fibrillation in patients aged \u226580 years","volume":"43","author":"Zhou","year":"2020","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.02.045_bib39","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.hlc.2022.02.003","article-title":"Evaluation of safety and effectiveness of catheter ablation of atrial fibrillation in patients aged \u226580 years","volume":"31","author":"Liu","year":"2022","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hrthm.2026.02.045_bib40","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s40266-013-0094-8","article-title":"Atrial fibrillation in the elderly","volume":"30","author":"Nantsupawat","year":"2013","journal-title":"Drugs Aging"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126002031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126002031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:42:06Z","timestamp":1782722526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527126002031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1547527126002031"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.02.045","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiarrhythmic drugs vs catheter ablation for treatment of atrial fibrillation in an elderly population: A retrospective analysis of Medicare Advantage enrollees in the United States","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.02.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}